openPR Logo
Press release

Ankylosing Spondylitis Pipeline Therapeutics Report for Companies and Drug Profile in H1 2017

06-02-2017 03:14 PM CET | Health & Medicine

Press release from: RNR Market Research

Ankylosing Spondylitis Pipeline Therapeutics Report for Companies and Drug Profile in H1 2017

Ankylosing Spondylitis Pipeline Therapeutics Report for Companies and Drug Profile in H1 2017

H1 Ankylosing Spondylitis pipeline report evaluates Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

Complete report @ http://www.rnrmarketresearch.com/ankylosing-spondylitis-bekhterevs-disease-pipeline-review-h1-2017-market-report.html

Main key players of Ankylosing Spondylitis pipeline are AbbVie Inc, Adello Biologics LLC, Allergan Plc, Alteogen Inc, Amgen Inc, Biocad, Biocon Ltd, Bionovis SA, Celgene Corp, Coherus BioSciences Inc, Galapagos NV, Genor BioPharma Co Ltd, Immunwork Inc, Innovent Biologics Inc, Johnson & Johnson, Merck KGaA, Momenta Pharmaceuticals Inc, Mycenax Biotech Inc, Novartis AG, Oncobiologics Inc, Protalix BioTherapeutics Inc, Reliance Life Sciences Pvt Ltd, Sandoz International GmbH, Shanghai Pharmaceutical Co Ltd, Sun Pharma Advanced Research Company Ltd, UCB SA, Xbrane Biopharma AB.

Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.

Discount Available at http://www.rnrmarketresearch.com/contacts/discount?rname=1028947 (This report is available at upto 25% Discount till June 02nd 2017.)

Ankylosing Spondylitis - Drug Profiles are apremilast, BAT-1406, BCD-085, bimekizumab, certolizumab pegol biosimilar, DNX-114, DNX-514, etanercept biosimilar, filgotinib, golimumab, HEISCO-III-002, infliximab biosimilar, risankizumab, secukinumab, TE-2122, TE-2158, thalidomide, tildrakizumab, upadacitinib tartrate, VTP-43742

Ankylosing Spondylitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev’s Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Order a copy of this research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=1028947

Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev’s Disease).
• The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterev’s Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterev’s Disease)

List of Figures
Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017

About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

2nd floor, metropole,
Next to inox theatre,
Bund garden road, Pune-411001.
+ 1 888 391 5441
sales@rnrmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis Pipeline Therapeutics Report for Companies and Drug Profile in H1 2017 here

News-ID: 562277 • Views:

More Releases from RNR Market Research

Emerging Trends Exosome Diagnostics and Therapeutics Market Dominated by Evox Th …
An exosome diagnostic and therapeutic study approach represents the opportunity to expand and develop the liquid biopsy market, a growing sector in cancer diagnostics. Once they reach the recipient cells, cytoplasmic ingredients can alter their biology. Access Sample Papers of Exosome Diagnostics and Therapeutics Market with 248 Pages and 6 Company Profiles Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1529771 . Growth in exosome diagnostic and therapeutic market in these regions attributes to the technological advancement in
17.8% CAGR for Care Management Solutions Market - Regions Like North America and Europe Drives the Growth
17.8% CAGR for Care Management Solutions Market - Regions Like North America and …
Key care management solutions market players are Allscripts Healthcare Solutions, Inc. (U.S.), TriZetto Corporation (U.S.), Phytel Inc. (U.S.), EXL Healthcare (U.S.), AxisPoint Health (U.S.), Wellcentive, Inc. (U.S.), Medecision, Inc. (U.S.), ZeOmega Inc. (U.S.), i2i Systems, Inc. (U.S.), HealthSmart Holdings, Inc. (U.S.), Pegasystems Inc. (U.S.), Epic Corporation Inc. (U.S.), and Harmony Information Systems, Inc. (U.S.) Download Brochure of Care Management Solutions Market spread across 191 pages, Profiling 15 Companies and Supported with
Global 5K Display Resolution Market: 2019 Industry Analysis, Size, Trends, Growth and Forecast 2025 | Canon Inc, Samsung Electronics, Sony Corporation, LG Electronics Inc, Sharp Corporation, Philips, HP, Others
Global 5K Display Resolution Market: 2019 Industry Analysis, Size, Trends, Growt …
This report presents the worldwide 5K Display Resolution Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Global 5K Display Resolution Market Report including definitions, classifications, applications and
Dialyzers Market 2019-2025: Global Consumption Value, Sales and Key Companies Pr …
The global Dialyzers Market 2019 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. This report presents the worldwide Dialyzers Market size (value, production and consumption), splits the breakdown (data status 2014-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market

All 5 Releases


More Releases for Ankylosing

Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/ Retail Pharmacy to Dominate the
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631 Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen
Ankylosing Spondylitis Treatment Market Research and Forecast 2020-2026
The global ankylosing spondylitis treatment market is projected to exhibit considerable growth during the forecast period (2020-2026). Ankylosing spondylitis is an inflammatory disease that leads to the fusion of some small bones of the spine (vertebrae) making the spine less flexible. The rising geriatric population is expected to be a major cause responsible for ankylosing spondylitis. The rising focus of the players operating in the ankylosing spondylitis market towards investment
Ankylosing Spondylitis Market Shares, Strategies and Forecast Worldwide, 2017 - …
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it
Ankylosing Spondylitis Treatment Market Pegged for Robust Expansion During 2015 …
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture.
Ankylosing Spondylitis Market : New Study Offers Insights for 2025
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it